ヒドロキシカルバミドの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)
Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth.
Scope of the Report:
This report focuses on the Hydroxycarbamide in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Capsule
Tablet
Market Segment by Applications, can be divided into
Sickle Cell Disease
Cancer
Other
There are 15 Chapters to deeply display the global Hydroxycarbamide market.
Chapter 1, to describe Hydroxycarbamide Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Hydroxycarbamide, with sales, revenue, and price of Hydroxycarbamide, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Hydroxycarbamide, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Hydroxycarbamide market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Hydroxycarbamide sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source